RDS congratulates Scientific Advisory Board member Ronald Evans, for being selected as the recipient of the 2012 Wolf Prize in Medicine. This recognition is Israel’s highest award for achievements benefitting mankind. Dr. Evans is a professor and head of Salk Institute’s Gene Expression Laboratory. The Wolf Prize jury selected Evans for his discovery of the gene super-family encoding nuclear receptors and elucidating the mechanism of action of this class of receptors. A major achievement in Evans’ lab was the discovery of a large family of of receptor molecules that respond to various steroid hormones, Vitamin A and thyroid hormones. These hormones help control sugar, salt, calcium and fat metabolism; thus, they impact on our daily health as well as treatment of disease. The receptors Evans discovered are primary targets in the treatment of breast cancer, prostate cancer and leukemia, as well as osteoporosis and asthma.